NCT06613971 · RECRUITING

Dynamic Light Scattering Ocular Measurement in the Detection of Dementia

This study uses a noninvasive eye scan called dynamic light scattering to see whether people with dementia have measurable differences in their eyes compared to people without dementia. It is not a treatment trial — no drugs or therapies are involved. The phase is unspecified, which usually means this is early exploratory research aimed at developing a potential diagnostic tool, not something proven or approved.

Eligibility criteria

1. All patients must be capable of an adequate ophthalmic evaluation and testing. This includes the ability to cooperate with the exam, sufficiently clear media (cornea, lens, vitreous) and sufficient pupillary dilation.
2. Patients must be capable of providing informed consent.
3. Patients who are not medically stable or who may be at significant risk to their health will not be eligible.
4. Women of child bearing age must not be pregnant at the time of examination.

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2025-05-08

View full record on ClinicalTrials.gov

All APOE4 clinical trials